Skip to content
  • About
  • Platform
  • Pipeline
  • Company
  • Partnering
  • Investors
  • News
  • Careers
  • Contact

Privacy and Terms

How this website handles your data, and the terms on which its content is offered.

Company Details

Aurelius Therapeutics B.V. is a private limited company under Dutch law with its statutory seat in Nijmegen. Registered office: Toernooiveld 300, 6525 EC Nijmegen, The Netherlands. Chamber of Commerce (KvK) 93277946. VAT identification number NL​[VAT number]. Email: info@aureliustherapeutics.com. Messages sent through the contact form or by email are answered within two working days.

Privacy Notice

Controller. Aurelius Therapeutics B.V., Toernooiveld 300, 6525 EC Nijmegen, The Netherlands (KvK 93277946). Contact: info@aureliustherapeutics.com.

What this site collects. Nothing by itself. This website sets no cookies, runs no analytics, and loads no third-party scripts or fonts. If you choose the dark color scheme, that choice is stored in your own browser and is not transmitted to us. Our hosting provider keeps standard server logs (IP address, requested page, time) for security, for a limited period.

Contact form and email. If you write to us, we keep your name, email address, and message for as long as is needed to answer you and to follow up on what you asked, and for no longer than twelve months after our last exchange unless the correspondence leads to an agreement. The legal basis is our legitimate interest in responding to inquiries (GDPR Art. 6(1)(f)), or the steps needed before entering into an agreement with you (Art. 6(1)(b)). Applications for positions are kept for the duration of the recruitment process and are deleted within four weeks of its end, unless you agree to a longer period of up to one year so that we can contact you about future positions. You can withdraw that agreement at any time.

Sharing. We do not sell or share personal data. Service providers that process data for us (email hosting, form handling) act on our instructions under data processing agreements. Where a provider processes data outside the European Economic Area, the transfer is covered by an adequacy decision or by the European Commission's standard contractual clauses.

Your rights. You can ask for access to, correction of, or deletion of your data, object to or restrict its processing, and ask for a copy in a portable form. Write to the address above. You can also complain to the Dutch Data Protection Authority (Autoriteit Persoonsgegevens).

Terms of Use

Information only. This website describes Aurelius Therapeutics and its research. It does not offer medical advice, and nothing on it should be used to make decisions about diagnosis or treatment. The products described are investigational and have not been approved by any regulatory authority.

Forward-looking statements. Statements about programs, timelines, expected results, and plans describe our current intentions, and are subject to the risks of drug development, including the possibility that a program does not progress.

Content. Text, figures, and the Aurelius marks are the property of Aurelius Therapeutics B.V. unless stated otherwise. Radionuclide data are evaluated values from public sources. You may quote from this site with attribution.

No offer of securities. Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy securities of Aurelius Therapeutics B.V. in any jurisdiction. Any offering is made only to qualified investors by private placement under the applicable exemptions, on the basis of separate offering documents.

Liability. We keep the site accurate to the best of our knowledge, but we accept no liability for loss arising from reliance on its content or from its unavailability. Dutch law applies.

Accessibility

Aurelius Therapeutics wants everyone to be able to read this website. It is built to the Web Content Accessibility Guidelines (WCAG) 2.2 at level AA: text and background colors meet the contrast minimum in both color schemes, every page can be used with a keyboard alone, images and figures carry text alternatives, and the animated backgrounds can be paused with the control in each banner and are turned off when a browser asks for reduced motion.

The site was last checked in October 2026 with automated testing (axe-core) on every page in both color schemes and on desktop and phone layouts, together with a keyboard review. No known limitations remain. If you find something that does not work for you, write to info@aureliustherapeutics.com and we will fix it.

Last updated October 2026.

Defend Patients, Defeat Cancer

Aurelius Therapeutics B.V.
Toernooiveld 300
6525 EC Nijmegen
The Netherlands

Statutory seat Nijmegen · Chamber of Commerce (KvK) 93277946 · VAT NL​[VAT number]
info@aureliustherapeutics.com

Company

  • About
  • Where we come from
  • Leadership
  • Board
  • Investors
  • Careers
  • News

Platform

  • The molecule
  • Discovery
  • Optimization
  • Radionuclides
  • Alpha and beta
  • Manufacturing

Work with us

  • Pipeline
  • Partnering
  • Contact

© 2026 Aurelius Therapeutics B.V.. All product candidates described on this site are investigational. None has been approved by the European Medicines Agency, the U.S. Food and Drug Administration, or any other regulatory authority, and their safety and efficacy have not been established.

Privacy and terms · Accessibility